News

The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

ANI Pharmaceuticals Launches Carbamazepine Extended-Release Capsules

Tuesday, April 14, 2026

ANI Pharmaceuticals Inc has announced the launch of Carbamazepine ExtendedRelease Capsules in strengths of mg mg and mg The product is a generic version of Carbatrol

Axplora Announces Expansion of R&D and Laboratory Hub at Farmabios Site in Italy

Tuesday, April 14, 2026

Axplora has announced plans to construct a new sqm RD and laboratory facility at its Farmabios site in Gropello Cairoli Italy to bolster manufacturing and innovation capabilities in the European pharma sector

Drug Manufacturing Deals Shift to Europe Amid US Decline and Pharma Tariffs

Monday, April 13, 2026

Europe has outpaced the US by more than threefold in contract manufacturing deals for FDAapproved drugs in marking a significant shift in the global pharma manufacturing landscape

EU 2026 Pharma Package Finalized: New Regulatory Framework Reshapes Exclusivity and Innovation Incentives

Friday, April 10, 2026

The EU Council has released the final texts of the Pharma Package introducing a flexible exclusivity model and new vouchers for antimicrobials amid ongoing legislative steps

Nxera Pharma Reaches Second Development Milestone in Eli Lilly Collaboration for Metabolic Diseases

Thursday, April 09, 2026

Nxera Pharma Co Ltd has reached a second development milestone under its multitarget collaboration and licence agreement with Eli Lilly and Company focused on diabetes and metabolic diseases

Axplora Invests €30 Million to Boost Lyophilization Capacity at Le Mans Facility

Thursday, April 09, 2026

Axplora announces a million investment to enhance lyophilization capabilities at its Le Mans manufacturing facility strengthening European pharma production capacity

EU Council Publishes Final 2026 Pharma Package: New Regulatory Framework for Medicinal Products

Wednesday, April 08, 2026

The EU Council has released the final texts of the comprehensive Pharma Package introducing flexible data protection periods orphan drug incentives and antimicrobial vouchers to boost innovation and access

Alloy Therapeutics Partners with Biogen on Multi-Target ASO Platform Collaboration

Wednesday, April 08, 2026

Alloy Therapeutics Inc has entered into a collaboration and licence agreement with Biogen Inc to support the development of antisense therapeutics using its proprietary AntiClastic ASO platform

Novo Foundation Pumps $850M into Denmark and Europe to Bolster Life Sciences Innovation

Tuesday, April 07, 2026

The Novo Foundation has announced an million investment to support biotech and pharma innovation across Denmark and Europe

EU Pharma Package Agreement Reached: Modernising Regulations for Medicinal Products and Enhancing Supply Security

Friday, April 03, 2026

The European Parliament and Council have agreed on the Pharma Package to modernise EU medicinal product regulations boost supply security and improve competitiveness